Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Ophthalmic Biopharmaceutical Ocuphire Pharma Shifts Focus To Gene Therapy Through Opus Genetics Stock Deal
Viatris and Ocuphire Pharma get FDA green light for eye treatment